Irampanel is a small molecule drug. Irampanel is under investigation in clinical trial NCT02222961 (Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers). Irampanel has a monoisotopic molecular weight of 309.15 Da.